A
ACW
ACTINOGEN MEDICAL
0.03
0.00-3.85%Closed16:10 01/22 AEDT
OPEN/PREV CLOSE0.026/0.026
TODAY RANGE0.025-0.026
VOL1.19M
MARKET CAP81.45M
52 WEEK RANGE0.021-0.099
AVG VOL (3M)5.84M
% TURNOVER0.01%
TURNOVER30.74K
P/E (TTM)-4.4068
% RANGE3.85%
EPS(TTM)-0.0059
P/E(FORWARD)-6.5000
P/B3.611
BVPS0.0072
DIVIDEND--
P/S260.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP68.94M
SHARES OUTSTANDING3.13B
NEXT EARNINGS02/23-02/27
FREE FLOAT2.65B
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
ASX·01/12 22:16
ACW presents at Sachs Neuro & WHO grants INN emestedastat
ASX·12/18/2024 21:18
Change in substantial holding
ASX·12/16/2024 06:06
Application for quotation of securities - ACW
ASX·12/13/2024 03:17
Listed Options Top 20&Distribution Schedule
ASX·12/13/2024 03:17
ACW to list $0.05 options exp 31 May 2027 - ASX code ACWOD
ASX·12/13/2024 03:17
Application for quotation of securities - ACW
PR Newswire·12/09/2024 13:00
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
ASX·12/08/2024 22:36
ACW randomizes first US participant in Alzheimers trial
ASX·12/05/2024 03:31
Application for quotation of securities - ACW
ASX·12/02/2024 23:56
Notification of cessation of securities - ACW
ASX·11/28/2024 05:24
Notification of cessation of securities - ACW
ASX·11/14/2024 00:58
Results of Annual General Meeting
ASX·11/13/2024 21:44
Actinogen 2024 AGM, Chairs address and CEOs presentation
ASX·11/11/2024 22:50
Actinogen receives $9.0 million R&D tax incentive rebate
ASX·11/05/2024 23:39
Notification of buy-back - ACW
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others